CL2013002985A1 - Compuestos derivados de aminometilfenilo biciclico, como moduladores del receptor de esfingosina-1-fosfato; composicion farmaceutica que los comprende; y su uso para tratar enfermedades oculares, enfermedades inflamatorias, enfermedades autoinmunes e inmunosupresion, aterosclerosis, enfermedad de alzheimer. - Google Patents

Compuestos derivados de aminometilfenilo biciclico, como moduladores del receptor de esfingosina-1-fosfato; composicion farmaceutica que los comprende; y su uso para tratar enfermedades oculares, enfermedades inflamatorias, enfermedades autoinmunes e inmunosupresion, aterosclerosis, enfermedad de alzheimer.

Info

Publication number: CL2013002985A1
Authority: CL; Chile
Prior art keywords: diseases; aminomethylphenyl; sphingosine; immunosuppression; atherosclerosis
Prior art date: 2011-04-14

Application number

CL2013002985A

Other languages

English (en)

Inventor

Wha Bin Im

Janet A Takeuchi

Ling Li

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-04-14

Filing date

2013-10-14

Publication date

2014-06-13

2013-10-14 Application filed by Allergan Inc filed Critical Allergan Inc

2014-06-13 Publication of CL2013002985A1 publication Critical patent/CL2013002985A1/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Pulmonology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)

CL2013002985A 2011-04-14 2013-10-14 Compuestos derivados de aminometilfenilo biciclico, como moduladores del receptor de esfingosina-1-fosfato; composicion farmaceutica que los comprende; y su uso para tratar enfermedades oculares, enfermedades inflamatorias, enfermedades autoinmunes e inmunosupresion, aterosclerosis, enfermedad de alzheimer. CL2013002985A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161475352P	2011-04-14	2011-04-14

Publications (1)

Publication Number	Publication Date
CL2013002985A1 true CL2013002985A1 (es)	2014-06-13

Family

ID=45998680

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2013002985A CL2013002985A1 (es)	2011-04-14	2013-10-14	Compuestos derivados de aminometilfenilo biciclico, como moduladores del receptor de esfingosina-1-fosfato; composicion farmaceutica que los comprende; y su uso para tratar enfermedades oculares, enfermedades inflamatorias, enfermedades autoinmunes e inmunosupresion, aterosclerosis, enfermedad de alzheimer.

Country Status (15)

Country	Link
US (4)	US8716267B2 (es)
EP (2)	EP2697212B1 (es)
JP (1)	JP2014511878A (es)
KR (1)	KR20140048874A (es)
CN (1)	CN103619828A (es)
AU (2)	AU2012242827A1 (es)
BR (1)	BR112013026507A2 (es)
CA (2)	CA2833313A1 (es)
CL (1)	CL2013002985A1 (es)
IL (1)	IL228850A0 (es)
MX (1)	MX2013011979A (es)
RU (1)	RU2013150173A (es)
SG (1)	SG194184A1 (es)
WO (2)	WO2012142288A1 (es)
ZA (1)	ZA201307796B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR112013026507A2 (pt) *	2011-04-14	2016-12-27	Allergan Inc	derivados de metil amina fenil bicíclicos como moduladores dos receptores de esfinfgosina-1 fosfato
CN112851562A (zh) *	2021-01-22	2021-05-28	烟台显华化工科技有限公司	一种芳香环液晶化合物及其液晶组合物和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1469863A2 (en) *	2002-01-18	2004-10-27	Merck & Co., Inc.	Selective s1p1/edg1 receptor agonists
EP1575964B1 (en) *	2002-01-18	2009-11-11	Merck & Co., Inc.	N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
EP1622866B1 (en) *	2003-04-30	2012-07-25	Novartis AG	Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
EP2644195A1 (en) *	2003-05-19	2013-10-02	Irm Llc	Immunosuppressant Compounds and Compositions
PL1638551T3 (pl) *	2003-05-19	2012-05-31	Irm Llc	Związki i kompozycje immunosupresyjne
CA2824106A1 (en) *	2003-08-29	2005-03-10	Ono Pharmaceutical Co., Ltd.	Compound capable of binding s1p receptor and pharmaceutical use thereof
CA2591399C (en) *	2004-12-13	2014-05-20	Ono Pharmaceutical Co., Ltd.	Aminocarboxylic acid derivative and medicinal use thereof
KR20080024533A (ko) *	2005-06-24	2008-03-18	액테리온 파마슈티칼 리미티드	신규한 티오펜 유도체
EP2017257B1 (en) *	2006-04-28	2014-08-06	Mitsubishi Tanabe Pharma Corporation	2-aminobutanol compound and use thereof for medical purposes
JP2009269819A (ja) *	2006-08-25	2009-11-19	Asahi Kasei Pharma Kk	アミン化合物
WO2008097819A2 (en) *	2007-02-05	2008-08-14	Smithkline Beecham Corporation	Chemical compounds
MX2010001446A (es) *	2007-08-08	2010-03-01	Merck Serono Sa	Derivados de 6-amino-pirimidina-4-carboxamida y compuestos relacionados que se enlazan a los receptores para esfingosina 1-fosfato (s1p) para el tratamiento de esclerosis multiple.
JP2010536791A (ja) *	2007-08-15	2010-12-02	ユニバーシティオブバージニアパテントファンデーション	二環式スフィンゴシン１−リン酸アナログ
AU2009323259A1 (en) *	2008-12-05	2011-06-23	Astellas Pharma Inc.	2H-chromene compound and derivative thereof
CN102712607B (zh) *	2009-11-24	2016-06-22	阿勒根公司	作为具有治疗效用的受体调节剂的化合物
AU2011332155A1 (en) *	2010-11-23	2013-07-04	Allergan, Inc.	Novel phosphonic acids as S1P receptor modulators
CA2833305A1 (en) *	2011-04-14	2012-10-18	Allergan, Inc.	Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
BR112013026507A2 (pt) *	2011-04-14	2016-12-27	Allergan Inc	derivados de metil amina fenil bicíclicos como moduladores dos receptores de esfinfgosina-1 fosfato
CA2833545A1 (en) *	2011-04-18	2012-10-26	Allergan, Inc.	Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators

2012
- 2012-04-12 BR BR112013026507A patent/BR112013026507A2/pt not_active IP Right Cessation
- 2012-04-12 SG SG2013076609A patent/SG194184A1/en unknown
- 2012-04-12 KR KR1020137030126A patent/KR20140048874A/ko not_active Withdrawn
- 2012-04-12 AU AU2012242827A patent/AU2012242827A1/en not_active Abandoned
- 2012-04-12 WO PCT/US2012/033321 patent/WO2012142288A1/en not_active Ceased
- 2012-04-12 MX MX2013011979A patent/MX2013011979A/es not_active Application Discontinuation
- 2012-04-12 CN CN201280028552.2A patent/CN103619828A/zh active Pending
- 2012-04-12 CA CA2833313A patent/CA2833313A1/en not_active Abandoned
- 2012-04-12 JP JP2014505281A patent/JP2014511878A/ja active Pending
- 2012-04-12 EP EP12716170.1A patent/EP2697212B1/en not_active Not-in-force
- 2012-04-12 RU RU2013150173/04A patent/RU2013150173A/ru not_active Application Discontinuation
- 2012-04-13 US US13/446,575 patent/US8716267B2/en not_active Expired - Fee Related
- 2012-04-13 EP EP12717536.2A patent/EP2696877A1/en not_active Withdrawn
- 2012-04-13 CA CA2833255A patent/CA2833255A1/en not_active Abandoned
- 2012-04-13 AU AU2012242652A patent/AU2012242652A1/en not_active Abandoned
- 2012-04-13 US US13/446,352 patent/US8541582B2/en not_active Expired - Fee Related
- 2012-04-13 WO PCT/US2012/033467 patent/WO2012142377A1/en not_active Ceased
2013
- 2013-07-08 US US13/936,891 patent/US8653050B2/en not_active Expired - Fee Related
- 2013-10-13 IL IL228850A patent/IL228850A0/en unknown
- 2013-10-14 CL CL2013002985A patent/CL2013002985A1/es unknown
- 2013-10-18 ZA ZA2013/07796A patent/ZA201307796B/en unknown
2014
- 2014-03-20 US US14/221,093 patent/US8946195B2/en active Active

Also Published As

Publication number	Publication date
JP2014511878A (ja)	2014-05-19
US8946195B2 (en)	2015-02-03
EP2697212B1 (en)	2015-09-09
CN103619828A (zh)	2014-03-05
CA2833255A1 (en)	2012-10-18
AU2012242652A1 (en)	2013-10-31
CA2833313A1 (en)	2012-10-18
US20140206652A1 (en)	2014-07-24
US8716267B2 (en)	2014-05-06
KR20140048874A (ko)	2014-04-24
EP2696877A1 (en)	2014-02-19
SG194184A1 (en)	2013-11-29
US8653050B2 (en)	2014-02-18
IL228850A0 (en)	2013-12-31
WO2012142377A1 (en)	2012-10-18
RU2013150173A (ru)	2015-05-20
ZA201307796B (en)	2014-07-30
BR112013026507A2 (pt)	2016-12-27
US20120264716A1 (en)	2012-10-18
US20120264718A1 (en)	2012-10-18
EP2697212A1 (en)	2014-02-19
MX2013011979A (es)	2014-02-06
US20130338108A1 (en)	2013-12-19
US8541582B2 (en)	2013-09-24
AU2012242827A1 (en)	2013-10-31
WO2012142288A1 (en)	2012-10-18

Publication	Publication Date	Title
CL2014003388A1 (es)	2015-04-10	Compuestos derivados de triazolona, como inhibidores de mpges-1; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende, util para el tratamiento de inflamacion, asma, epoc, artritis, enfermedad de parkinson y enfermedades autoinmunes, entre otras enfermedades.
CL2014000806A1 (es)	2014-09-05	Compuestos derivados de 1-arilcarbonil-4-oxi-piperidino; composicion farmaceutica que los comprende; uso para la prevencion o el tratamiento de enfermedades neurodegenerativas tales como enfermedad de alzheimer, enfermedad de parkinson, enfermedad de huntington o esclerosis multiple.
CL2015002123A1 (es)	2015-12-04	Moduladores de receptores nmda de espiro-lactama y sus usos
CL2015000956A1 (es)	2015-06-19	Compuestos derivados de pirrolotriazinona como inhibidores de pi3k; composicion farmaceutica que los comprende; combinacion farmaceutica; uso para tratar enfermedades respiratorias, autoinmunes, trastornos neurologicos, cardiovasculares, metabolicos, entre otros.
DOP2016000295A (es)	2017-03-15	Compuestos y composiciones como agonistas del receptor tipo toll 7
EA201491530A1 (ru)	2015-07-30	Модуляторы рецепторов эстрогенов и их применение
EA201491161A1 (ru)	2014-11-28	Фторированные модуляторы рецепторов эстрогенов и их применение
EP2812004A4 (en)	2015-11-11	COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCLE ATROPHY
EP2872493A4 (en)	2016-04-13	COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCLE ATROPHY
CL2014002412A1 (es)	2015-03-06	Compuestos derivados de pirido[4,3-d]pirimidina, como inhibidores de mek; composicion farmaceutica que los comprende; y su uso para el tratamiento de enfermedades inflamatorias, infecciones, trastornos autoinmunes, enfermedades metabolicas y enfermedades malignas, entre otras.
BR112014024941A2 (pt)	2017-09-19	dispositivo de imagem de campo de visão amplo com capacidade de focalização ativa
CL2015000295A1 (es)	2015-04-24	Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CL2014001090A1 (es)	2014-08-01	Compuestos derivados de oxazolidinona biciclica; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como aterosclerosis y dislipidemia.
CL2014001853A1 (es)	2015-06-26	Compuestos derivados de pirrol sustituido; procedimiento de preparacion; composicion farmaceutica que los contiene; combinacion farmaceutica; uso para tratar enfermedades tales como canceres y enfermedades del sistema inmunitario.
UY35177A (es)	2014-06-30	Novedosos derivados de bencimidazol como antagonistas de ep4
CL2016001595A1 (es)	2017-01-13	Moduladores de tetrahidropiridopirazinas de gpr6.
PT2919796T (pt)	2021-06-02	Utilização de akkermansia para o tratamento de distúrbios metabólicos
DK2872151T3 (da)	2019-12-02	Acellulære pro-tolerogene sammensætninger til behandling/forebyggelse af autoimmune sygdomme
PE20150631A1 (es)	2015-05-11	Formas cristalinas de un modulador del receptor androgenico
MX2017000135A (es)	2017-04-10	Moduladores del receptor arilo y metodos para elaborar y usar los mismos.
CL2015002125A1 (es)	2015-12-04	Moduladores de receptores nmda de espiro-lactama y sus usos.
EA033811B1 (ru)	2019-11-27	Стабильные бесконсервантные мидриатические и противовоспалительные растворы для инъекций
MX2018011453A (es)	2019-01-10	Moduladores alostericos de receptores de acetilcolina nicotinicos.
EP2715634A4 (en)	2014-11-26	RECONFIGURATION OF A DYNAMIC PLATFORM BY MULTICULTURAL SERVICE PROVIDERS
UY36224A (es)	2016-01-29	Compuestos tricíclicos de imidazo-pirimidinona